Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Drug Pricing & Economics

Peter Bach

MD, MAPP

🏢Memorial Sloan Kettering Cancer Center🌐USA

Former Director, Center for Health Policy and Outcomes

85
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Peter Bach was the director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering, where he created the Drug Abacus tool for assessing cancer drug value and became one of the most prominent voices for cancer drug pricing reform. His research documenting the disconnect between cancer drug prices and clinical benefit galvanized public debate and policy action. His analyses of Medicare Part B drug spending and proposals for value-based pricing frameworks have been influential in shaping oncology reimbursement policy.

Share:

🧪Research Fields 研究领域

Cancer drug value assessment
Drug pricing transparency
Medicare cancer drug costs
Value-based cancer care
Oncology cost-effectiveness

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Peter Bach 的研究动态

Follow Peter Bach's research updates

留下邮箱,当我们发布与 Peter Bach(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment